Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles.
BACKGROUND
Hodgkin's lymphoma is characterized by the presence of mono-nucleated Hodgkin cells and bi- to multi-nucleated Reed-Sternberg cells. We have recently shown telomere dysfunction and aberrant synchronous/asynchronous cell divisions during the transition of Hodgkin cells to Reed-Sternberg cells.1


METHODS
To determine whether overall changes in nuclear architecture affect genomic instability during the transition of Hodgkin cells to Reed-Sternberg cells, we investigated the nuclear organization of chromosomes in these cells.


RESULTS
Three-dimensional fluorescent in situ hybridization revealed irregular nuclear positioning of individual chromosomes in Hodgkin cells and, more so, in Reed-Sternberg cells. We characterized an increasingly unequal distribution of chromosomes as mono-nucleated cells became multi-nucleated cells, some of which also contained chromosome-poor 'ghost' cell nuclei. Measurements of nuclear chromosome positions suggested chromosome overlaps in both types of cells. Spectral karyotyping then revealed both aneuploidy and complex chromosomal rearrangements: multiple breakage-bridge-fusion cycles were at the origin of the multiple rearranged chromosomes. This conclusion was challenged by super resolution three-dimensional structured illumination imaging of Hodgkin and Reed-Sternberg nuclei. Three-dimensional super resolution microscopy data documented inter-nuclear DNA bridges in multi-nucleated cells but not in mono-nucleated cells. These bridges consisted of chromatids and chromosomes shared by two Reed-Sternberg nuclei. The complexity of chromosomal rearrangements increased as Hodgkin cells developed into multi-nucleated cells, thus indicating tumor progression and evolution in Hodgkin's lymphoma, with Reed-Sternberg cells representing the highest complexity in chromosomal rearrangements in this disease.


CONCLUSIONS
This is the first study to demonstrate nuclear remodeling and associated genomic instability leading to the generation of Reed-Sternberg cells of Hodgkin's lymphoma. We defined nuclear remodeling as a key feature of Hodgkin's lymphoma, highlighting the relevance of nuclear architecture in cancer.
Guffei
Amanda
A
Manitoba Institute of Cell Biology, University of Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada.
Sarkar
Rahul
R
Klewes
Ludger
L
Righolt
Christiaan
C
Knecht
Hans
H
Mai
Sabine
S
D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism*; D002869:Chromosome Aberrations; D019457:Chromosome Breakage; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D006689:Hodgkin Disease / Q000235:genetics* / Q000473:pathology; D006801:Humans; D016539:Reed-Sternberg Cells / Q000378:metabolism / Q000473:pathology; D032681:Spectral Karyotyping / Q000379:methods; D014178:Translocation, Genetic
Curr Opin Cell Biol. 2006 Jun;18(3):307-16
16687245
Environ Mol Mutagen. 2009 Oct;50(8):741-7
19326465
Int J Cancer. 2002 Jun 10;99(5):665-72
12115499
Leukemia. 2000 Oct;14(10):1803-14
11021756
J Microsc. 2001 Nov;204(Pt 2):99-107
11737543
J Natl Cancer Inst. 2004 Feb 18;96(4):305-15
14970279
EMBO J. 2009 Sep 2;28(17):2532-40
19629041
Cytogenet Genome Res. 2007;116(1-2):1-11
17268171
Cancer Res. 1998 Sep 1;58(17):3974-85
9731511
J Exp Med. 1999 Jun 21;189(12):1939-46
10377189
J Cell Sci. 2008 Jun 1;121(11):1876-86
18477608
Blood. 2002 Jun 15;99(12):4283-97
12036854
Nat Rev Genet. 2007 Feb;8(2):104-15
17230197
Chromosoma. 2006 Dec;115(6):459-67
16897100
J Cell Biochem. 2010 Apr 15;109(6):1095-102
20127711
Proc Natl Acad Sci U S A. 1942 Nov;28(11):458-63
16578057
Nat Rev Cancer. 2009 Jan;9(1):15-27
19078975
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5541-6
15809428
Oncogene. 2003 Apr 3;22(13):1978-87
12673203
Leukemia. 2009 Mar;23(3):565-73
19039323
Semin Cancer Biol. 2007 Feb;17(1):1-4
17158061
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9613-8
15983382
Bioessays. 2004 Nov;26(11):1164-74
15499579
Lab Invest. 2010 Apr;90(4):611-9
20142802
Cell. 2009 Apr 17;137(2):356-68
19379699
Lancet. 1991 Feb 9;337(8737):320-2
1671232
Nat Genet. 2004 Sep;36(9):932-4
15340427
Leukemia. 2003 Nov;17(11):2214-9
14523479
Oncogene. 2010 Jan 28;29(4):503-15
19881539
Hematology Am Soc Hematol Educ Program. 2009;:497-506
20008235
Neoplasia. 2007 Jul;9(7):578-88
17710161
Blood. 1993 Nov 15;82(10):2937-42
8219183
Am J Pathol. 2004 Mar;164(3):925-35
14982846
Cancer Cell. 2008 Dec 9;14(6):431-3
19061834
Blood. 2009 Jun 4;113(23):5920-6
19188663
Adv Exp Med Biol. 2005;570:393-421
18727509
Exp Hematol. 2006 Apr;34(4):399-406
16569586
Chromosoma. 1999 Dec;108(7):426-35
10654081
Genetics. 1941 Mar;26(2):234-82
17247004
Nature. 2004 Sep 23;431(7007):461-6
15329734